Trovagene (TROV) Misses Q3 EPS by 1c

Trovagene (NASDAQ: TROV) reported Q3 EPS of ($0.34), $0.01 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $89 thousand versus the consensus estimate of $320 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c